ALLO Operating Income Growth
Allogene Therapeutics Inc · Operating Income Growth
ALLO Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported29.09%period ending
ALLO TTM Operating Income YoY % (-6.68% → 29.09%)
Year-over-year change
High-resolution chart · PNG
ALLO operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 29.0856% | |
| 29.2578% | |
| 23.3837% | |
| 23.661% | |
| 12.0479% | |
| 9.8345% | |
| 16.6573% | |
| 12.1294% | |
| 19.3559% | |
| 15.8892% | |
| 2.2796% | |
| -8.3184% | |
| -16.3382% | |
| -17.1737% | |
| -31.1408% | |
| -24.5584% | |
| -27.5282% | |
| -29.4416% | |
| 0.9487% | |
| 0.8656% | |
| -0.5012% | |
| -4.7176% | |
| -27.838% | |
| -48.6729% | |
| -74.6591% | |
| 1.5333% | |
| -4.7531% | |
| -6.6841% |